Grahaprima Suksesmandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Grahaprima Suksesmandiri Tbk. trades at Rp212 (market cap 416.76B, 218.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 24.2K 24h volume). The key difference: Grahaprima Suksesmandiri Tbk. is far larger — about 2.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Grahaprima Suksesmandiri Tbk. is more actively traded (218.4K versus 24.2K). Which is the better fit depends on your goals.
| GTRA | OBAT | |
|---|---|---|
Market Cap | 416.76B | 167.37B |
Volume | 218.4K | 24.2K |
Lot | 2.18K | 242 |
Turnover | 46.62M | 5.98M |
Average Price | 213.47 | 246.98 |
Value | 46.62M | 5.98M |
Indicative Equilibrium Price | 222 | 246 |
Indicative Equilibrium Volume | 82 | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Grahaprima Suksesmandiri Tbk (the “Company”) was established on August 11, 2004 based onNotarial Deed No. 15 of Hermanto, S.H., notary in Bekasi. The Company started its commercial operations on 2006.
Read more on GTRA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →